Replies to post #20665 on Momenta Pharmaceuticals, Inc. (MNTA)

[floblu14]

Timing trades?

As posted earlier - at the 2019 annual meeting, CW stated face to face that their 3 top programs were worth $6B EACH. Furthermore, an analyst had quoted that for each billion the stock would rise $30 PS. Simple math?

BTW at their last QCC, CW stated that Necuparanib would be tested on Covid 19. Time has passed - what were the results?

They take care of their own. What else is new?

Watch RVNC & ENTA. :-)